Handbuch ADHS

Shaw P, Sharp WS, Morrison M, Eckstrand K, Greenstein DK, Clasen LS, Evans AL, Rapoport JL (2009). Psychostimulant Treatment and the developing cortex in attention deficit hyperactivity. Am J Psychiatry 166(1): 58–63.

Shaywitz BA, Cohen DJ et al. (1977). CSF monoamine metabolites in children with minimal brain dysfunction: evidence for alteration of brain dopamine. A preliminary report. J Pediatr 90(1): 67–71.

Sheehan K, Lowe N et al. (2005). Tryptophan hydroxylase 2 (TPH2) gene variants associated with ADHD. Mol Psychiatry 10(10): 944–9.

Sheehan K, Hawi Z et al. (2007). No association between TPH2 gene polymorphisms and ADHD in a UK sample. Neurosci Lett 412(2): 105–7.

Shekim WO, Bylund DB et al. (1986). Platelet MAO and measures of attention and impulsivity in boys with attention deficit disorder and hyperactivity. Psychiatry Res 18(2): 179–88.

Shetty T, Chase TN (1976). Central monoamines and hyperkinase of childhood. Neurology 26(10): 1000–2.

Sikstrom S, Soderlund G (2007). Stimulus-dependent dopamine release in attention-deficit/hyperactivity disorder. Psychol Rev 114(4): 1047–75.

Solanto MV (2002). Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research. Behav Brain Res 130(1–2): 65–71.

Spivak B, Vered Y et al. (1999). Circulatory levels of catecholamines, serotonin and lipids in attention deficit hyperactivity disorder. Acta Psychiatr Scand 99(4): 300–4.

Tripp G, Wickens JR (2008). Research review: dopamine transfer deficit: a neurobiological theory of altered reinforcement mechanisms in ADHD. J Child Psychol Psychiatry 49(7): 691–704.

Volkow ND, Ding YS et al. (1995). Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 52(6): 456–63.

Volkow ND, Wang G et al. (2001). Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 21(2): RC121.

Walitza S, Renner TJ et al. (2005). Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder. Mol Psychiatry 10(12): 1126–32.

Watanabe Y, Fujita M et al. (1997). Brain dopamine transporter in spontaneously hypertensive rats. J Nucl Med 38(3): 470–4.

Wilens TE (2008). Effects of Methylphenidate on the Catecholaminergic Sytstem in Attention-Deficit/Hyperactivity Disorder. J Clin Psychopharmcaol 28 (Suppl. 2): S46–S53.

Williams J (2008). Working toward a neurobiological account of ADHD: commentary on Gail Tripp and Jeff Wickens, dopamine transfer deficit. J Child Psychol Psychiatry 49(7): 705–11; discussion 711.

Yano M, Steiner H (2005). Methylphenidate (Ritalin) induces Homer 1a and zif 268 expression in specific corticostriatal circuits. Neuroscience 132(3): 855–65.

Zhang K, Davids E et al. (2002). Serotonin transporter binding increases in caudate-putamen and nucleus accumbens after neonatal 6-hydroxydopamine lesions in rats: implications for motor hyperactivity. Brain Res Dev Brain Res 137(2): 135–8.

4Noradrenalin wird international i. d. R. als Norepinephrin benannt, weswegen hier auch die Abkürzung NE benutzt wird.

Текст предоставлен ООО «ЛитРес».

Прочитайте эту книгу целиком, купив полную легальную версию на ЛитРес.

Безопасно оплатить книгу можно банковской картой Visa, MasterCard, Maestro, со счета мобильного телефона, с платежного терминала, в салоне МТС или Связной, через PayPal, WebMoney, Яндекс.Деньги, QIWI Кошелек, бонусными картами или другим удобным Вам способом.